These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 19779621)

  • 21. miR-181a/b significantly enhances drug sensitivity in chronic lymphocytic leukemia cells via targeting multiple anti-apoptosis genes.
    Zhu DX; Zhu W; Fang C; Fan L; Zou ZJ; Wang YH; Liu P; Hong M; Miao KR; Liu P; Xu W; Li JY
    Carcinogenesis; 2012 Jul; 33(7):1294-301. PubMed ID: 22610076
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of microRNAs in regulation of the TNF/TNFR gene superfamily in chronic lymphocytic leukemia.
    Srivastava S; Tsongalis GJ; Kaur P
    Clin Biochem; 2016 Nov; 49(16-17):1307-1310. PubMed ID: 27544753
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MiR-15a and miR-16-1 cluster functions in human leukemia.
    Calin GA; Cimmino A; Fabbri M; Ferracin M; Wojcik SE; Shimizu M; Taccioli C; Zanesi N; Garzon R; Aqeilan RI; Alder H; Volinia S; Rassenti L; Liu X; Liu CG; Kipps TJ; Negrini M; Croce CM
    Proc Natl Acad Sci U S A; 2008 Apr; 105(13):5166-71. PubMed ID: 18362358
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NDRG2 mRNA levels and miR-28-5p and miR-650 activity in chronic lymphocytic leukemia.
    Yang YQ; Tian T; Zhu HY; Liang JH; Wu W; Wu JZ; Xia Y; Wang L; Fan L; Li JY; Xu W
    BMC Cancer; 2018 Oct; 18(1):1009. PubMed ID: 30348117
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Small RNAs analysis in CLL reveals a deregulation of miRNA expression and novel miRNA candidates of putative relevance in CLL pathogenesis.
    Marton S; Garcia MR; Robello C; Persson H; Trajtenberg F; Pritsch O; Rovira C; Naya H; Dighiero G; Cayota A
    Leukemia; 2008 Feb; 22(2):330-8. PubMed ID: 17989717
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential microRNA profiles and their functional implications in different immunogenetic subsets of chronic lymphocytic leukemia.
    Papakonstantinou N; Ntoufa S; Chartomatsidou E; Papadopoulos G; Hatzigeorgiou A; Anagnostopoulos A; Chlichlia K; Ghia P; Muzio M; Belessi C; Stamatopoulos K
    Mol Med; 2013 May; 19(1):115-23. PubMed ID: 23615967
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of mutated IGHV3-23 genes in chronic lymphocytic leukemia identifies a disease subset with peculiar clinical and biological features.
    Bomben R; Dal-Bo M; Benedetti D; Capello D; Forconi F; Marconi D; Bertoni F; Maffei R; Laurenti L; Rossi D; Del Principe MI; Luciano F; Sozzi E; Cattarossi I; Zucchetto A; Rossi FM; Bulian P; Zucca E; Nicoloso MS; Degan M; Marasca R; Efremov DG; Del Poeta G; Gaidano G; Gattei V
    Clin Cancer Res; 2010 Jan; 16(2):620-8. PubMed ID: 20068100
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of mir-15a/16-1 in early B cell development in a mouse model of chronic lymphocytic leukemia.
    Underbayev C; Kasar S; Ruezinsky W; Degheidy H; Schneider JS; Marti G; Bauer SR; Fraidenraich D; Lightfoote MM; Parashar V; Raveche E; Batish M
    Oncotarget; 2016 Sep; 7(38):60986-60999. PubMed ID: 27533467
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic lymphocytic leukemia: molecular genetics and animal models.
    Pekarsky Y; Calin GA; Aqeilan R
    Curr Top Microbiol Immunol; 2005; 294():51-70. PubMed ID: 16323427
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Critical role of microRNAs in chronic lymphocytic leukemia: overexpression of the oncogene PLAG1 by deregulated miRNAs.
    Patz M; Pallasch CP; Wendtner CM
    Leuk Lymphoma; 2010 Aug; 51(8):1379-81. PubMed ID: 20687796
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential roles of miR-15a/16-1 and miR-497/195 clusters in immune cell development and homeostasis.
    Hutter K; Rülicke T; Drach M; Andersen L; Villunger A; Herzog S
    FEBS J; 2021 Mar; 288(5):1533-1545. PubMed ID: 32705746
    [TBL] [Abstract][Full Text] [Related]  

  • 32. microRNA fingerprinting of CLL patients with chromosome 17p deletion identify a miR-21 score that stratifies early survival.
    Rossi S; Shimizu M; Barbarotto E; Nicoloso MS; Dimitri F; Sampath D; Fabbri M; Lerner S; Barron LL; Rassenti LZ; Jiang L; Xiao L; Hu J; Secchiero P; Zauli G; Volinia S; Negrini M; Wierda W; Kipps TJ; Plunkett W; Coombes KR; Abruzzo LV; Keating MJ; Calin GA
    Blood; 2010 Aug; 116(6):945-52. PubMed ID: 20393129
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monoallelic and biallelic deletions of 13q14.3 in chronic lymphocytic leukemia: FISH vs miRNA RT-qPCR detection.
    Smonskey MT; Block AW; Deeb G; Chanan-Khan AA; Bernstein ZP; Miller KC; Wallace PK; Starostik P
    Am J Clin Pathol; 2012 Apr; 137(4):641-6. PubMed ID: 22431542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. miR deregulation in CLL.
    Balatti V; Pekarky Y; Rizzotto L; Croce CM
    Adv Exp Med Biol; 2013; 792():309-25. PubMed ID: 24014303
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Defective DROSHA processing contributes to downregulation of MiR-15/-16 in chronic lymphocytic leukemia.
    Allegra D; Bilan V; Garding A; Döhner H; Stilgenbauer S; Kuchenbauer F; Mertens D; Zucknick M
    Leukemia; 2014 Jan; 28(1):98-107. PubMed ID: 23974981
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular characterization of chronic lymphocytic leukemia patients with a high number of losses in 13q14.
    Rodríguez AE; Hernández JÁ; Benito R; Gutiérrez NC; García JL; Hernández-Sánchez M; Risueño A; Sarasquete ME; Fermiñán E; Fisac R; de Coca AG; Martín-Núñez G; de Las Heras N; Recio I; Gutiérrez O; De Las Rivas J; González M; Hernández-Rivas JM
    PLoS One; 2012; 7(11):e48485. PubMed ID: 23152777
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of miRNA-15 and miRNA-16 expression replacement in chronic lymphocytic leukemia: implication for therapy.
    Cutrona G; Matis S; Colombo M; Massucco C; Baio G; Valdora F; Emionite L; Fabris S; Recchia AG; Gentile M; Neumaier CE; Reverberi D; Massara R; Boccardo S; Basso L; Salvi S; Rosa F; Cilli M; Zupo S; Truini M; Tassone P; Calabrese M; Negrini M; Neri A; Morabito F; Fais F; Ferrarini M
    Leukemia; 2017 Sep; 31(9):1894-1904. PubMed ID: 28053325
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemia.
    Fulci V; Chiaretti S; Goldoni M; Azzalin G; Carucci N; Tavolaro S; Castellano L; Magrelli A; Citarella F; Messina M; Maggio R; Peragine N; Santangelo S; Mauro FR; Landgraf P; Tuschl T; Weir DB; Chien M; Russo JJ; Ju J; Sheridan R; Sander C; Zavolan M; Guarini A; Foà R; Macino G
    Blood; 2007 Jun; 109(11):4944-51. PubMed ID: 17327404
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interleukin 21 Controls mRNA and MicroRNA Expression in CD40-Activated Chronic Lymphocytic Leukemia Cells.
    De Cecco L; Capaia M; Zupo S; Cutrona G; Matis S; Brizzolara A; Orengo AM; Croce M; Marchesi E; Ferrarini M; Canevari S; Ferrini S
    PLoS One; 2015; 10(8):e0134706. PubMed ID: 26305332
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Karyotype-specific microRNA signature in chronic lymphocytic leukemia.
    Visone R; Rassenti LZ; Veronese A; Taccioli C; Costinean S; Aguda BD; Volinia S; Ferracin M; Palatini J; Balatti V; Alder H; Negrini M; Kipps TJ; Croce CM
    Blood; 2009 Oct; 114(18):3872-9. PubMed ID: 19717645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.